Metabolic associated fatty liver disease increases risk of adverse events after acute coronary syndrome

被引：0
|
作者：
Chew, N. [1 ]
Ng, C. H. [2 ]
Kong, G. [2 ]
Chin, Y. H. [2 ]
Lim, O. [3 ]
Lim, W. H. [3 ]
Dalakoti, M. [3 ]
Khoo, C. M. [2 ]
Kong, W. [1 ]
Poh, K. K. [1 ]
Foo, R. [1 ]
Lee, C. H. [1 ]
Chan, M. Y. [1 ]
Muthiah, M. [2 ]
Loh, P. H. [1 ]
机构：
[1] Natl Univ Heart Ctr, Singapore, Singapore
[2] Natl Univ Hlth Syst, Singapore, Singapore
[3] Natl Univ Singapore, Singapore, Singapore
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1414 / 1414
页数：1
相关论文
共 50 条
  • [41] Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events *
    Klingenberg, Roland
    Aghlmandi, Soheila
    Gencer, Baris
    Nanchen, David
    Raber, Lorenz
    Carballo, David
    Carballo, Sebastian
    Stahli, Barbara E.
    Landmesser, Ulf
    Rodondi, Nicolas
    Mach, Francis
    Windecker, Stephan
    Bucher, Heiner C.
    Eckardstein, Arnold von
    Loscher, Thomas F.
    Matter, Christian M.
    ATHEROSCLEROSIS, 2021, 320 : 31 - 37
  • [42] Metabolic dysfunction associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Kim, Aryoung
    Choi, Sung Chul
    Goh, Myungji
    Kang, Wonseok
    Gwak, Geum-Yon
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    Sinn, Dong Hyun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S631 - S631
  • [43] Risk of Adverse Events in Anticoagulated Patients With Atrial Fibrillation and Nonalcoholic Fatty Liver Disease
    Bucci, Tommaso
    Nabrdalik, Katarzyna
    Baratta, Francesco
    Pastori, Daniele
    Pignatelli, Pasquale
    Hydes, Theresa
    Alam, Uazman
    Violi, Francesco
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (01): : 208 - 217
  • [44] Plasma Omega-6 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome
    Zelniker, Thomas A.
    Morrow, David A.
    Mozaffarian, Dariush
    Guo Jianping
    Im, KyungAh
    Sabatine, Marc S.
    O'Donoghue, Michelle L.
    CIRCULATION, 2018, 138
  • [45] Hyperinsulinemia after pancreas transplantation: a risk for excessive weight gain, metabolic syndrome, and fatty liver disease
    Knight, Richard
    Islam, Ana
    Patel, Samir
    Sadhu, Archana
    Teeter, Larry
    Graviss, Edward
    Victor, David
    Gabor, Osama
    TRANSPLANTATION, 2016, 100 (07) : S16 - S16
  • [46] Prognostic model of adverse coronary events risk assessment in patients with ST-elevation acute coronary syndrome after percutaneous coronary intervention
    Berns, S. A.
    Shmidt, E. A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 361 - 361
  • [47] Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
    Gao, Feng
    Zheng, Kenneth, I
    Wang, Xiao-Bo
    Yan, Hua-Dong
    Sun, Qing-Feng
    Pan, Ke-Hua
    Wang, Ting-Yao
    Chen, Yong-Ping
    George, Jacob
    Zheng, Ming-Hua
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (01) : 204 - 207
  • [48] Leukocyte count as a risk factor for coronary adverse events among patients admitted for an acute coronary syndrome
    Cabrerizo G, Jose Luis
    Zalba E, Begona
    Perez C, Juan I.
    Ruiz R, Francisco
    REVISTA MEDICA DE CHILE, 2010, 138 (03) : 274 - 280
  • [49] Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation
    Sprinzl, Martin F.
    Weinmann, Arndt
    Lohse, Nikola
    Toenissen, Hanna
    Koch, Sandra
    Schattenberg, Joern
    Hoppe-Lotichius, Maria
    Zimmermann, Tim
    Galle, Peter R.
    Hansen, Torsten
    Otto, Gerd
    Schuchmann, Marcus
    TRANSPLANT INTERNATIONAL, 2013, 26 (01) : 67 - 74
  • [50] Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
    Gitto, Stefano
    Villa, Erica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04) : 1 - 11
12345